Role of tumour markers in monitoring epithelial ovarian cancer
T Meyer, G J Rustin, T Meyer, G J Rustin
Abstract
Currently the only tumour marker to have a well-defined and validated role in the management of ovarian cancer is CA125. Changes in the level of CA125 can be used as a reliable indication of response or progression according to various criteria, but it does not yet have a clear place in diagnosis or prognosis. Its value as part of a screening tool and during routine follow-up remain the subject of ongoing trials. Other markers remain experimental and do not have a well-defined contribution to make at present.
References
- Am J Obstet Gynecol. 1989 Nov;161(5):1213-6
- J Clin Oncol. 1996 May;14(5):1545-51
- Cancer. 1995 Nov 15;76(10 Suppl):2004-10
- Gynecol Oncol. 1992 Oct;47(1):87-92
- J Clin Oncol. 1999 Feb;17(2):501-8
- Br J Obstet Gynaecol. 1990 Oct;97(10):922-9
- Gynecol Oncol. 1996 Feb;60(2):197-202
- BMJ. 1993 Apr 17;306(6884):1030-4
- Cancer. 1996 Jul 1;78(1):118-27
- Cancer Res. 1998 May 1;58(9):1843-9
- Int J Gynecol Cancer. 1993 Sep;3(5):285-292
- Gynecol Oncol. 1993 Dec;51(3):297-8
- Cancer Treat Rev. 1995 May;21(3):215-45
- N Engl J Med. 1983 Oct 13;309(15):883-7
- Obstet Gynecol. 1995 Aug;86(2):259-64
- Am J Clin Oncol. 1982 Dec;5(6):649-55
- Ann Oncol. 1993;4 Suppl 4:71-7
- Lancet. 1999 Apr 10;353(9160):1207-10
- Lancet. 1988 Feb 6;1(8580):268-71
- Gynecol Oncol. 1988 Jul;30(3):307-12
- Obstet Gynecol. 1987 Feb;69(2):223-7
- Gynecol Oncol. 1995 Oct;59(1):111-6
- J Clin Invest. 1981 Nov;68(5):1331-7
- Ann Oncol. 1996 Apr;7(4):361-4
- Obstet Gynecol. 1986 Apr;67(4):473-7
- Cancer. 1981 Jan 1;47(1):207-14
- J Natl Cancer Inst. 1993 Nov 3;85(21):1748-51
- Ann Oncol. 1997 Oct;8(10):963-8
- Am J Clin Oncol. 1989 Apr;12(2):106-9
- Gynecol Oncol. 1994 Jun;53(3):339-43
- Obstet Gynecol. 1992 Jul;80(1):14-8
- J Clin Oncol. 1993 Aug;11(8):1506-10
- Eur J Cancer. 1992;28(1):79-82
- Ann Oncol. 1990 Jul;1(4):301-2
Source: PubMed